Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation
Our results indicated that patients who were positive for HLA antibodies were at a greater risk of developing GF/PGF. Co-infusion with UCBs was safe and improved engraftment, cGVHD, and improved the 1-year RFS to some extent.
Authors
- Huiting Qu (ORCID: https://orcid.org/0000-0003-2921-841X)
- Changqing Zhen (ORCID: https://orcid.org/0000-0002-2873-7309)
- Xiaosheng Fang (ORCID: https://orcid.org/0000-0002-4515-9731)
- Peipei Li (ORCID: https://orcid.org/0000-0001-8246-4578)
- Na Wang (ORCID: https://orcid.org/0000-0001-9552-0524)
- Yuan Dai (ORCID: https://orcid.org/0009-0001-6017-4956)
- Hongzhi Xu (ORCID: https://orcid.org/0000-0002-7772-1506)
- Yujie Jiang (ORCID: https://orcid.org/0000-0003-2199-238X)
- Kang Lu (ORCID: https://orcid.org/0000-0003-1047-1378)
- Yuying Wang (ORCID: https://orcid.org/0009-0003-3740-8472)
- Yiou Zhao
- Mei Ding (ORCID: https://orcid.org/0000-0001-8146-1535)
- Xiao Lv
Institutions
- Changchun University of Science and Technology (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3389/fimmu.2024.1459699
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.45